Preventative Medicine Flashcards Preview

► USMLE 2 > Preventative Medicine > Flashcards

Flashcards in Preventative Medicine Deck (66):
1

screenning test for pancreatic cancer

no test for that

2

why use ca 19-9

evaluation of the response to treatment

3

recommended vaccine in hiv(2)

the same guideline as normal individual
exception for live attenuated vaccine

4

When should be given Tetanos diphteria

q 10 ans

5

CAT in patient more than 65 ans who has never received tetanus toxoid

one dose of Tdap before receiving any booster

6

quid of Tdap(2)

tetanos
acellular petussis

7

smoking cessation(3)

bupropion
counselling
nicotine replacement

8

quid of bupropion(2)

antidepressant
approved by FDA

9

other drug used in smoking cessation and action.(2)

varenicline
partial agonist of nicotinic acetylcholine receptor

10

patient with anti HBS-antibody positive has AES in patient positive for Hep B CAT?

do nothing

11

patient with with unknown statut has AES in patient positive for Hep B CAT?

Immune globulin
vaccination series for Hep B

12

CAT in patient diabetic 40-75 ans with ten year cardiovascular risk

lifestyle modification
moderate statin use

13

when to begin prostate screening(3)

controversy
some say 40
some say case by case approach

14

screening of prostate cancer(2)

Psa
digital exam

15

recommendation for tetanos and diphteria prevention

starting after 18
TD q 10 ans
or for all ages Tdap at single dose

16

indication of pneumococcal vaccine in

chronic lung disease
chronic CV disease
diabetes mellitus
chronic liver disease
immunocpmpromised patient
functional or anatomic asplenia
alcoholism
cigarette
cochlear inplant
CSF leak

17

quid of chronic lung disease(3)

asthme
bronchite chronique
emphysema

18

cause of functionnal asplenia(4)

sickle cell disease
hemoglobinopathy
splenectomy
acquired asplenism

19

people who can receive intranasal influenza

healthy individual

20

people who cant receive intranasal influenza
what should be given

immunocompromised patient
intramuscular influenza vaccine

21

way to prevent decubitus ulcer(2)

change position q 2h
pressure reducing devices

22

patient at risk for decubitus ulcer(3)

immobility
poor nutrition
sensory impairment

23

quid of pressure reducing devices

air and foam mattress

24

when to screen breast cancer and when to start

q 2 ans
starting 50

25

when generally breast cancer is no more important

after 75

26

when to screen cervical cancer and when start(2)

q 3 ans
21 ans

27

frequency of screening for cervical cancer in 30-65 ans

q 5 ans
par smear et serology HPV

28

when to screen cervical cancer in immunocompromised patient(hiv,tranplanted or immunosuppresive drug)and frequency(2)

at the onset of sexual activity
annually but twice in the first year

29

screening for colon cancer in patient with parent killed by the ca

begin ten years earlier

30

screening for colon cancer in patient in general and frequency(2)

50 ans
q 10 ans

31

way of screening colon cancer(5)

fecal occult blood in feces
colonoscopy
Flexible sigmoidoscopy
FOBT plus flexible sigmoidoscopy
double contrast bayum enema

32

patient with cd4 less than 200 what vaccines should not be done to this patient

MMR
varicella
zoster
intranasal influenza

33

dose of Hep A vaccine in HIV patient or in general(2)

2 doses
the second a 6 mois de la premiere dose

34

dose of hep B in HIV or in general situation

3 doses
o month,1 month,4 month

35

frequency of Hi flu

one dose in infancy

36

best rx for claudication

exercice program

37

what should receive any patient with atherosclerotic risk(2)
(PAD)

statin
aspirin

38

criteria to scren abdominal aneurism

smoker
> 65

39

frequency of screening for abdominal aneurism

one time

40

way of screening abdominal aneurism

U/S

41

number of dose of PPSV(pneumonia vaccine)(2)

1 or 2(repeat in 5 yars)
more than 65 years one dose

42

patient going to egypt important vaccine to be given(or north africa or any developing country)(4)

-Hep A
Hep B
typhoide
Polyo

43

CAT in patient with atherosclerotic risk disease 75 ans

high intensity statin

44

CAT in patient with atherosclerotic risk disease > 75 ans

moderate intensity statin

45

quid of atherosclerotic disease(3)

stroke
pad
CAD

46

CAT in LDL >/190 mg/dl

high intensity statin

47

diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk >/ 7,5

high intensity statin

48

diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk

moderate intensity statin

49

patient with 10 year atherosclerotic cardiovascular risk >/ 7,5

moderate to high intensity statin

50

prevention of influenza in immunocompromised patient

IM influenza vaccine

51

mechanism of action of pneumococcal pneumoniae prevention using the polyvalent pneumococcal vaccine

T-cell independent B cell response

52

why polyvalent pneumococal vaccine cannot activate T cell(2)

because it's just polysaccharides of the 23 most prevalent types of pneumococcus
polysaccharides cannot be presented to t cell

53

quid of heptavalent pneumococcus vaccine(2)

use in children
t cell dependent b cell response

54

screnning test in any sexually active women

chlamydia trachomatis

55

risk for bladder cancer(2)

smoking
industrial chemical

56

screening of bladder cancer

no screening

57

when to screen patient for osteoporosis

starting after 65 ans

58

quid of osteoporosis

bone density > 2,5 of standard deviation or
T

59

quid of osteopenia

T entre -1 et -2,5

60

the most important risk factor for osteoporosis in the US

post menopause

61

risk factor for osteoporosis(6)

poor intake of VitD and calcium
smoking
common steroid use
lack of weight bearing exercice
low body mass index

62

secondary cause of osteoporosis(11)

premature menopause
hypogonadism
malabsorption disease
IBD
rhumatoid arthritis
cushing syndrome
hyperthyroidism
hyperparathyroidism
vit D deficiency
chronic liver disese
renal disease

63

screening test for hyperlipidemia in men when to start and frequency(2)

> 35 ans
lipid panel q 5 ans

64

when mamo is no longer important in screening breast ca

after 75 ans

65

high intensity statin(2)

atorvastatin 40-80
rosuvastatin 20-40 mg

66

moderate intensity statin(5)

atorvastatin 10-20 mg
rosuvastatin 5-10
simvastatin 20-40
pravastatin 40-80
lovastatin 40